Eva Cerqueira-Gonzalez
Research Subjects
Research Interests
Eva Cerqueira-Gonzalez has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Ana De Malet
Clinical Microbiology,University Hospital Complex Of Vigo,Vigo,Spain; Microbiology and Infectology Research GroupGalicia Sur Health Research Institute,Vigo,Spain, Spain
1 shared publication - Carmen Potel
Microbiology Department, Complexo Hospitalario Universitario de Vigo, Vigo, Pontevedra, Spain
1 shared publication - Diego Solla-Medal
Clinical Microbiology,University Hospital Complex Of Vigo,Vigo,Spain, Spain
1 shared publication - Francisco Jose Vasallo Vidal
Clinical Microbiology,Complejo Hospitalario de Vigo,Vigo,Spain; Microbiology and Infectology Research Group,Galicia Sur Biomedical Foundation,Vigo,Spain, Spain
1 shared publication - Iván Pensado-Mendez
Diasorin Iberia S.Aalcobendas,Spain, Spain
1 shared publication
Latest Publications
- Open Access
- 28 September 2026
- Published by MDPI AG in Preprints.org
Evaluation of Luminex® NxTAG® and Seegene Allplex™ Gastrointestinal Panels Using the Automated STARlet AIOS System from Stool Specimens
Gastroenteritis remains a leading cause of morbidity worldwide. Although conventional stool culture and microscopy are considered the reference standards for diagnosis, they are time-consuming and their performance may be affected by prior antibiotic use. Molecular syndromic panels offer a rapid alternative for the simultaneous detection of a wide range of gastrointestinal pathogens. Objective: This study aimed to evaluate the diagnostic performance and clinical utility of two molecular syndromic panels, the Seegene Allplex™ Gastrointestinal Multiplex PCR Assay on the automated STARlet AIOS platform (SGN) and the Luminex NxTAG® Gastrointestinal Pathogen Panel (LMX), using stool specimens collected in Cary-Blair medium, compared with conventional diagnostic methods. Methods: A total of 124 stool specimens from patients with suspected gastrointestinal infection were analyzed. Diagnostic performance and inter-method agreement were assessed using Positive Percent Agreement (PPA), Negative Percent Agreement (NPA), and Cohen's kappa (κ), both before and after comparison with the reference standard (stool culture and microscopy). Results: Both molecular methods significantly increased pathogen detection, identifying 19 additional pathogens with SGN and 38 with LMX compared with the reference standard. Overall agreement between the two molecular assays was excellent (κ ≥ 0.80), although lower concordance was observed for Salmonella spp. (κ = 0.20) and Adenovirus (κ = 0.65). LMX showed 100% sensitivity for Salmonella spp. but generated a high number of unconfirmed positive results. Both platforms doubled the detection rate of Giardia lamblia compared with microscopy. Conclusion: Both molecular platforms are robust tools for the rapid detection of gastrointestinal pathogens, significantly improving diagnostic yield and supporting earlier clinical decision-making. However, unconfirmed positive results should be interpreted with caution and correlated with clinical findings. A combined diagnostic strategy, using rapid multiplex PCR screening alongside conventional methods, may provide the greatest clinical value by integrating rapid pathogen detection with antimicrobial susceptibility testing and the probability of epidemiological surveillance.
- 28 September 2026
- Published by MDPI AG in Preprints.org
Open AccessEvaluation of Luminex® NxTAG® and Seegene Allplex™ Gastrointestinal Panels Using the Automated STARlet AIOS System from Stool Specimens
Gastroenteritis remains a leading cause of morbidity worldwide. Although conventional stool culture and microscopy are considered the reference standards for diagnosis, they are time-consuming and their performance may be affected by prior antibiotic use. Molecular syndromic panels offer a rapid alternative for the simultaneous detection of a wide range of gastrointestinal pathogens. Objective: This study aimed to evaluate the diagnostic performance and clinical utility of two molecular syndromic panels, the Seegene Allplex™ Gastrointestinal Multiplex PCR Assay on the automated STARlet AIOS platform (SGN) and the Luminex NxTAG® Gastrointestinal Pathogen Panel (LMX), using stool specimens collected in Cary-Blair medium, compared with conventional diagnostic methods. Methods: A total of 124 stool specimens from patients with suspected gastrointestinal infection were analyzed. Diagnostic performance and inter-method agreement were assessed using Positive Percent Agreement (PPA), Negative Percent Agreement (NPA), and Cohen's kappa (κ), both before and after comparison with the reference standard (stool culture and microscopy). Results: Both molecular methods significantly increased pathogen detection, identifying 19 additional pathogens with SGN and 38 with LMX compared with the reference standard. Overall agreement between the two molecular assays was excellent (κ ≥ 0.80), although lower concordance was observed for Salmonella spp. (κ = 0.20) and Adenovirus (κ = 0.65). LMX showed 100% sensitivity for Salmonella spp. but generated a high number of unconfirmed positive results. Both platforms doubled the detection rate of Giardia lamblia compared with microscopy. Conclusion: Both molecular platforms are robust tools for the rapid detection of gastrointestinal pathogens, significantly improving diagnostic yield and supporting earlier clinical decision-making. However, unconfirmed positive results should be interpreted with caution and correlated with clinical findings. A combined diagnostic strategy, using rapid multiplex PCR screening alongside conventional methods, may provide the greatest clinical value by integrating rapid pathogen detection with antimicrobial susceptibility testing and the probability of epidemiological surveillance.